Issues related to Medicare reimbursement for Part D drugs; Issues related to CY2020 End Stage Renal Disease (ERSD) Prospective Payment System; Medigap insurance access for ESRD beneficiaries; S. 1676, Chronic Kidney Disease Improvement in Research and Treatment Act of 2019; H.R. 3436, Seniors' Chronic Care Management Improvements Act of 2019; H.R. 3912, Chronic Kidney Disease Improvement in Research and Treatment Act of 2019 Issues related to Medicare reimbursement for Part D drugs; Issues related to CY2020 End Stage Renal Disease (ESRD) Prospective Payment System; Medigap insurance access for ESRD beneficiaries; S. 1676, Chronic Kidney Disease Improvement in Research and Treatment Act of 2019;H.R. 3436, Senior's Chronic Care Management Improvement Act of 2019; H.R. 3912, Chronic Kidney Disease Improvement in Research and Treatment Act of 2019
HCR - Health Issues MMM - Medicare/Medicaid
136 - Centers For Medicare and Medicaid Services (CMS) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 136 - Centers For Medicare and Medicaid Services (CMS) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
AKEBIA THERAPEUTICS, INC.
245 First Street, Suite 1100, Cambridge, MA, 02142, US
SARA FROELICH SARA FROELICH